This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Outcomes of a Deep Inferior Epigastric Perforator Flap Program

This study is currently recruiting participants.
See Contacts and Locations
Verified March 2017 by Bernard T. Lee, Beth Israel Deaconess Medical Center
Sponsor:
Information provided by (Responsible Party):
Bernard T. Lee, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00543907
First received: October 12, 2007
Last updated: March 9, 2017
Last verified: March 2017
  Purpose
The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program.

Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Outcomes of a Deep Inferior Epigastric Perforator Flap Program

Resource links provided by NLM:


Further study details as provided by Bernard T. Lee, Beth Israel Deaconess Medical Center:

Primary Outcome Measures:
  • reconstruction rate [ Time Frame: 6 years ]

Secondary Outcome Measures:
  • complication rate, patient satisfaction, costs, referral pattern [ Time Frame: 6 years ]

Estimated Enrollment: 2400
Study Start Date: September 2007
Estimated Study Completion Date: September 2020
Estimated Primary Completion Date: September 2020 (Final data collection date for primary outcome measure)
Groups/Cohorts
Pre programmatic development
Patients who have undergone mastectomy for breast cancer prior to implementation of the deep inferior epigastric perforator flap microsurgical breast reconstruction program
Post programmatic development
Patients who have undergone mastectomy for breast cancer after implementation of the deep inferior epigastric perforator flap microsurgical breast reconstruction program

Detailed Description:
The purpose of this study is to analyze an institution's experience with starting a subspecialized DIEP flap program and to determine whether other hospitals would benefit from instituting a similar program. Prior studies have compared the outcome from a DIEP flap program with that of TRAM flaps within the same center. Other studies have calculated the cost of a DIEP flap and its complication rate. However, no one has examined the overall effects of a subspecialized reconstruction program and its impact on a health center. In this study, we will determine if the institutionalization of a DIEP flap program has increased our center's rate of breast reconstruction, as well as evaluate its outcomes and overall financial viability.
  Eligibility

Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All women who have undergone mastectomy for breast cancer between 2001 and 2007 at the BIDMC.
Criteria

Inclusion Criteria:

  • Intraductal carcinoma
  • Lobular carcinoma
  • Infiltrating ductal carcinoma
  • Paget's disease
  • BRCA positive

Exclusion Criteria:

  • Inflammatory carcinoma of the breast
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00543907

Contacts
Contact: Bernard T Lee, MD 617.632.7835 blee3@bidmc.harvard.edu

Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center Recruiting
Boston, Massachusetts, United States, 02215
Contact: Bernard T Lee, MD    617-632-7835    blee3@bidmc.harvard.edu   
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Investigators
Principal Investigator: Bernard T Lee, MD Beth Israel Deaconess Medical Center
  More Information

Responsible Party: Bernard T. Lee, Associate Professor of Surgery, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT00543907     History of Changes
Other Study ID Numbers: 2007P000232
Study First Received: October 12, 2007
Last Updated: March 9, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Bernard T. Lee, Beth Israel Deaconess Medical Center:
breast reconstruction
DIEP flap

ClinicalTrials.gov processed this record on July 21, 2017